These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 12125602)
1. Proceedings of the 10th International Vasculitis and ANCA Workshop. April 25-28, 2002. Cleveland, Ohio, USA. Cleve Clin J Med; 2002; 69 Suppl 2():SII1-196. PubMed ID: 12125602 [No Abstract] [Full Text] [Related]
2. 1996 International meeting on ANCA and ANCA-related diseases. The 7th International ANCA Workshop. Rochester, Minnesota, October 14-16, 1996. Proceedings and abstracts. Sarcoidosis Vasc Diffuse Lung Dis; 1996 Oct; 13(3):207-84. PubMed ID: 9035837 [No Abstract] [Full Text] [Related]
3. Abstracts from the 12th International Vasculitis and ANCA Workshop. June 15-18, 2005. Heidelberg, Germany. Kidney Blood Press Res; 2005; 28(3):155-99. PubMed ID: 16163809 [No Abstract] [Full Text] [Related]
4. [Antineutrophil cytoplasmic antibodies (ANCA). Their contribution to the pathogenesis of vasculitis]. Mirapeix E Med Clin (Barc); 1998 Jun; 110(20):778-80. PubMed ID: 9666419 [No Abstract] [Full Text] [Related]
6. Systemic small vessel vasculitis: pathophysiological aspects of antineutrophil cytoplasm antibodies (ANCA). A review on recent findings. Wiik A Autoimmun Rev; 2004 Jun; 3 Suppl 1():S51-3. PubMed ID: 15309795 [No Abstract] [Full Text] [Related]
7. The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitis. Schreiber A; Kettritz R J Leukoc Biol; 2013 Oct; 94(4):623-31. PubMed ID: 23381471 [TBL] [Abstract][Full Text] [Related]
8. Serial ANCA testing has limited value during the follow-up of disease activity in patients with ANCA-associated vasculitis. Lesavre P; Kyndt X; Vanhille P; Reumaux D; Guillevin L; Noël LH Sarcoidosis Vasc Diffuse Lung Dis; 1996 Oct; 13(3):246-8. PubMed ID: 8946593 [No Abstract] [Full Text] [Related]
9. [Antineutrophil cytoplasmic antibody (ANCA). Diagnostic tool in small vessel vasculitis]. Skogh T; Dahle L Lakartidningen; 1997 Mar; 94(10):854-7. PubMed ID: 9102513 [No Abstract] [Full Text] [Related]
10. ANCA vasculitis meets epigenetics--closing in on the molecular roots of disease. Zeisberg M Nephrol Dial Transplant; 2011 Apr; 26(4):1146-8. PubMed ID: 21273237 [No Abstract] [Full Text] [Related]
11. ANCA defines the clinical disease manifestations of vasculitis. The "con" side of the issue. Colby TV Sarcoidosis Vasc Diffuse Lung Dis; 1996 Oct; 13(3):227-9. PubMed ID: 8946587 [No Abstract] [Full Text] [Related]
12. ANCA-associated renal vasculitis. Savage CO Kidney Int; 2001 Oct; 60(4):1614-27. PubMed ID: 11576386 [No Abstract] [Full Text] [Related]
13. ANCA-associated vasculitides. Immunological and clinical aspects. Proceedings of the 4th International Workshop on ANCA and the 2nd International Colloquium on Wegener's Granulomatosis and Vasculitic Disorders. May 28-30, 1992, Lübeck, Germany. Adv Exp Med Biol; 1993; 336():1-549. PubMed ID: 8296595 [No Abstract] [Full Text] [Related]
15. Serial ANCA testing is useful in monitoring disease activity of patients with ANCA-associated vasculitides. Tervaert JW; Stegeman CA; Kallenberg CG Sarcoidosis Vasc Diffuse Lung Dis; 1996 Oct; 13(3):241-5. PubMed ID: 8946592 [No Abstract] [Full Text] [Related]
16. The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil. Gao Y; Chen M; Ye H; Guo XH; Zhao MH; Wang HY Int Immunopharmacol; 2007 Jan; 7(1):55-60. PubMed ID: 17161817 [TBL] [Abstract][Full Text] [Related]